Skip to main content
Clinical Trials/NCT03811405
NCT03811405
Completed
Not Applicable

Physiology, Imaging and Modeling of Deep Brain Stimulation for Essential Tremor

University of Florida2 sites in 1 country12 target enrollmentApril 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Essential Tremor
Sponsor
University of Florida
Enrollment
12
Locations
2
Primary Endpoint
Volume of tissue activated from stimulation with ET DBS
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

This project aims to investigate novel ways to deliver brain stimulation to Essential Tremor (ET) patients by introducing software changes to their existing devices. The study team aims to investigate safety and efficacy of these new stimulation parameters in patients with ET.

Detailed Description

Deep brain stimulation (DBS) is a neuromodulatory therapy that is effective in a subset of well selected essential tremor (ET) patients. However, as many as 1/5 of patients may initially improve, but then steadily worsen following the operation. The investigators developed a technique to study a variety of alternative stimulation methods without the use of an invasive repeat surgical intervention. The electrophysiological effects of non-conventional DBS differ from traditional DBS, however the physiological differences in the setting of human tremor remain largely unknown. This study plans to explore gaps in knowledge of neuromodulation and will collect and contribute essential information to the underlying mechanism of action of DBS. The hypothesis of this project centers around active biphasic stimulation providing a wider therapeutic window and a lower adverse event profile as compared to conventional DBS.

Registry
clinicaltrials.gov
Start Date
April 1, 2021
End Date
June 1, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Existing unilateral or bilateral VIN DBS for ET, non-demented (MMSE\>24), and must have a documented suboptimal tremor suppression on two successive visits (compared to the baseline post-operative improvement at 6 months following ET DBS surgery). For bilateral cases, the most affected tremor side will be studied.

Exclusion Criteria

  • No diagnosis of Essential Tremor

Outcomes

Primary Outcomes

Volume of tissue activated from stimulation with ET DBS

Time Frame: up to 24 hours

The study team will use computer simulation and virtual reconstruction of the brain from pre-operative MRI data to calculate the volume of tissue activated (VTA) from the novel stimulation patterns. The investigators will assess the feasibility of the patterns to address the worsening of ET that may occur in 20% or more of the ET population.

Baseline DBS settings versus active biphasic pulse DBS settings

Time Frame: up to 1 hour

The investigators will compare the degree of tremor suppression from the most optimal DBS settings that can be obtained via traditional programming methods versus active biphasic DBS. The degree of tremor will be quantified by multiple clinical metrics including the Fahn-Tolosa-Marin Tremor Rating Scale and Kinesia ONE® accelerometer system.

Secondary Outcomes

  • Tremor motor physiology(up to 15 minutes)
  • The Fahn-Tolosa-Marin Tremor Rating Scale(up to 15 minutes)
  • Gait impairment(up to 15 minutes)

Study Sites (2)

Loading locations...

Similar Trials